Michael Strupp
16Patents
4h-index
9Co-inventors
53Inventor score
Filing activity: Aug 2, 2002 → Jul 10, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7560848B2 | Electrical machine with commutator rotor | Electricity | 10 | Expired |
| US8157524B2 | Axial flow fan with hub isolation slots | Mechanical Engineering; Lighting; Heating | 8 | Active |
| US7248004B2 | Cooling fan, in particular for motor vehicles | Mechanical Engineering; Lighting; Heating | 4 | Expired |
| US10905670B2 | Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility and cognitive function | Human Necessities | 4 | Active |
| US11083718B2 | Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject | Human Necessities | 2 | Active |
| US11998518B2 | Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility and cognitive function | Human Necessities | 2 | Active |
| US11471434B2 | Treatment for migraine | Human Necessities | 1 | Active |
| US9476426B2 | Vibration isolating engine cooling fan | Electricity | 1 | Active |
| US8651814B2 | Axial flow fan with hub isolation slots | Mechanical Engineering; Lighting; Heating | 1 | Active |
| US11690830B2 | Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject | Human Necessities | 1 | Active |
| US12329733B2 | Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility and cognitive function | Human Necessities | 0 | Active |
| US7683561B2 | Device for the incremental control of a direct-current motor for the cooling fan of a motor vehicle | Electricity | 0 | Expired |
| US12144792B2 | Therapeutic agents for neurodegenerative diseases | Human Necessities | 0 | Active |
| US11660279B2 | Therapeutic agents for treating restless leg syndrome | Human Necessities | 0 | Active |
| US12121513B2 | Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject | Human Necessities | 0 | Active |
| US11400067B2 | Pharmaceutical compositions and uses directed to lysosomal storage disorders | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.